Edap Tms S.A. (NASDAQ:EDAP) – Research analysts at B. Riley lifted their Q3 2021 earnings per share (EPS) estimates for Edap Tms in a report issued on Wednesday, May 12th. B. Riley analyst A. D’silva now anticipates that the medical equipment provider will post earnings per share of $0.02 for the quarter, up from their previous forecast of $0.01. B. Riley currently has a “Buy” rating and a $13.00 target price on the stock.
Edap Tms (NASDAQ:EDAP) last issued its earnings results on Tuesday, May 11th. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. The company had revenue of $12.35 million for the quarter, compared to the consensus estimate of $12.33 million. Edap Tms had a negative return on equity of 11.54% and a negative net margin of 4.03%.
Shares of EDAP opened at $5.88 on Monday. The business’s 50 day moving average is $7.87 and its 200 day moving average is $6.85. The company has a market capitalization of $195.89 million, a PE ratio of -98.00 and a beta of 1.92. Edap Tms has a 12-month low of $2.07 and a 12-month high of $10.68. The company has a current ratio of 2.18, a quick ratio of 1.68 and a debt-to-equity ratio of 0.05.
Several institutional investors have recently made changes to their positions in the company. Captrust Financial Advisors purchased a new position in shares of Edap Tms in the 1st quarter worth approximately $34,000. Personal CFO Solutions LLC boosted its holdings in Edap Tms by 11.1% during the 4th quarter. Personal CFO Solutions LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $233,000 after acquiring an additional 4,500 shares during the period. Allworth Financial LP purchased a new position in Edap Tms during the 1st quarter valued at $50,000. Fosun International Ltd boosted its holdings in Edap Tms by 9.5% during the 4th quarter. Fosun International Ltd now owns 194,710 shares of the medical equipment provider’s stock valued at $964,000 after acquiring an additional 16,825 shares during the period. Finally, HRT Financial LP purchased a new position in Edap Tms during the 1st quarter valued at $161,000.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution.
Read More: The limitations of an equal weight rating
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.